Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Phase 1 Recruiting
40 enrolled
PROPS GYN
Phase 2 Recruiting
25 enrolled
(TRUS)
Recruiting
17 enrolled
Azenosertib in Uterine Serous Carcinoma: Biomarker Study
Phase 2 Recruiting
25 enrolled
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
Phase NA Recruiting
60 enrolled
(CLOCS-2)
Recruiting
2,900 enrolled
Image-Guided Gynecologic Brachytherapy
Phase NA Recruiting
54 enrolled
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
Phase 1 Recruiting
36 enrolled
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Phase 1 Recruiting
49 enrolled
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
Phase 1/2 Recruiting
54 enrolled
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
Phase 2 Recruiting
32 enrolled
Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery
Phase NA Recruiting
50 enrolled
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
Recruiting
1,000 enrolled
OvAR-Y
Recruiting
10 enrolled
MySaturn
Recruiting
111 enrolled
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Phase 1 Recruiting
30 enrolled
[18F]FES PET/.CT in Uterine Cancer
Phase 2 Recruiting
30 enrolled
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
Phase 1/2 Recruiting
37 enrolled
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
Phase NA Recruiting
192 enrolled
NYSCF Scientific Discovery Biobank
Recruiting
10,000 enrolled
GYNCOG
Phase NA Recruiting
60 enrolled
Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
Recruiting
580 enrolled
Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer.
Phase NA Recruiting
20,000 enrolled
Evaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms
Recruiting
3,000 enrolled
FAST
Phase NA Recruiting
30 enrolled
Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.
Recruiting
200 enrolled
PAM-II
Phase 2 Recruiting
12 enrolled
RetroBT
Recruiting
300 enrolled